Clinical Outcomes of Patients with Depression Treated with Either Duloxetine, Escitalopram, Fluoxetine, Paroxetine or Sertraline

Sep 27, 2018 | Chinese Research, CNS, Depression

Dovepress reports that Duloxetine-treated patients had better 6-month outcomes in terms of depression severity and clinical and functional remission, compared with selective serotonin reuptake inhibitor-treated patients.

Investigators included:

Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Medical Department, Eli Lilly and Company, Shanghai, China

Research, Teaching and Innovation Unit, Parc Sanitari Sant Joan De Déu, CIBERSAM, Universitat de Barcelona, Sant Boi De Llobregat, Barcelona, Spain

Health Outcomes, Eli Lilly and Company, Windlesham, Surrey, UK

State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, CAS, Shanghai, China; 6Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China